ALDEN CANCER THERAPY AS

ASActive

Org 912772438Thormøhlens Gate 51, 5006 BergenResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20130 employees

Overview Financials People & ownership Related companies

ALDEN CANCER THERAPY AS is a Norwegian AS based in Bergen, operating in the Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk sector. Incorporated in 2013, the company has 0 employees and reported revenue of NOK 0 in its latest annual filing.

Revenue 2024

NOK 0

EBITDA margin

—

-1% vs 2023

Equity ratio

-154.1%

Financial strength

Net profit 2024

NOK -1,9M

0% vs 2023

EBITDA — year on year

NOK millions

Key figures

Annual report 2024

Revenue	NOK 0	—
EBITDA	NOK -1,4M	-1%
Net profit	NOK -1,9M	+0%
Total assets	NOK 1,8M	-38%
Equity	NOK -2,8M	-207%
Employees	0	—

Contact

Address

Thormøhlens Gate 51, 5006 Bergen

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of ALDEN CANCER THERAPY AS?

ALDEN CANCER THERAPY AS is registered with Brønnøysundsregistrene under Org 912772438.

Who is the CEO of ALDEN CANCER THERAPY AS?

Karl Henning Kalland is Chief Executive Officer of ALDEN CANCER THERAPY AS, in role since 2013.

Who is the chairman of ALDEN CANCER THERAPY AS?

Bjørn Tore Gjertsen chairs the board of ALDEN CANCER THERAPY AS, in role since 2022.

Where is ALDEN CANCER THERAPY AS headquartered?

ALDEN CANCER THERAPY AS's registered address is Thormøhlens Gate 51, 5006 Bergen.

ALDEN CANCER THERAPY AS

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on ALDEN CANCER THERAPY AS

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on ALDEN CANCER THERAPY AS